Realizing the benefits of human genetics and genomics research for people everywhere.
A new report commissioned by ASHG examines how human genetics and genomics is growing the U.S. economy and becoming increasingly integrated in healthcare and society. The new report, titled “The Economic Impact and Functional Applications of Human Genetics and Genomics,” indicates that the human genetics and genomics sector contributes $265 billion to the U.S. economy... Read More
Posted By: Lyly Luhachack, PhD, Policy & Advocacy Specialist, ASHG April 22, 2021, marked the first-ever ASHG Capitol Hill Day. The Government and Public Advocacy Committee (GPAC), ASHG President Gail Jarvik, MD, PhD, Dana Crawford, PhD, Diversity, Equity, and Inclusion Task Force (DEITF) Chair, and leaders of the Career Development Committee (CDC) met, virtually, with... Read More
ASHG supports the nomination of Eric Lander, PhD, to lead the Office of Science and Technology Policy (OSTP). The announcement of the new team at the dawn of President Biden’s presidency, and elevating the Director of OSTP to a Cabinet position, is a positive sign that science, and scientists, will have a core role in... Read More
Professional Practice and Social Implications Committee (PPSI) Co-chairs Kyle Brothers, MD, PhD, and Sarah Tishkoff, PhD, recently organized a session titled, “Polygenic Risk Scores: Uses and Misuses in Health, Research, and Society.” They held the session on February 10, 2021, part of the American Association for the Advancement of Science (AAAS) 2021 Annual Meeting, to... Read More
The first few weeks of 2021 have brought numerous changes to the federal policy landscape, including the beginning of the new Biden Administration, a new Congress with a Democratic majority in both the Senate and the House of Representatives, and the deadly January 6 attack on the U.S. Capitol and its fallout. While these events... Read More